Skip to search form
Skip to main content
Semantic Scholar's Logo
You are currently offline. Some features of the site may not work correctly.
National Institutes of Health
Semantic Scholar uses AI to extract papers important to this topic.
Phase I clinical and pharmacokinetic study of an one-hour infusion of ormaplatin (NSC 363812)
Investigational New Drugs
Corpus ID: 7451665
Ormaplatin (NSC 363812, tetraplatin) is a stable platinum (IV) analog which has exhibited activity against cisplatin-resistant…
Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule.
Corpus ID: 14004621
Ormaplatin (tetraplatin, NSC 363812) is a platinum(IV) analogue that is active against cisplatin-resistant cell lines in…
Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812)
D. V. Von Hoff
Corpus ID: 45535824
Ormaplatin Is a platinum analog that was developed because of an altered toxlclty profile and non-cross resistance to clsplatln…
Comparative toxicity and renal distribution of the platinum analogs tetraplatin, CHIP, and cisplatin at equimolar doses in the Fischer 344 rat.
J. H. Smith
Fundamental and applied toxicology : official…
Corpus ID: 21156473
Tetraplatin [tetrachloro(dl-trans)1,2-diaminocyclohexane platinum(IV), NSC-363812] is a new anticancer platinum drug analog…
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Terms of Service
ACCEPT & CONTINUE